Ekman S - Search Results

1

Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review.

Blomberg C, Nilsson J, Holgersson G, Edlund P, Bergqvist M, Adwall L, Ekman S, Brattström D, Bergström S. Blomberg C, et al. Among authors: ekman s. Anticancer Res. 2015 May;35(5):2493-501. Anticancer Res. 2015. PMID: 25964522 Review.

2

Role of circulating cytokeratin fragments and angiogenic factors in NSCLC patients stage IIIa-IIIb receiving curatively intended treatment.

Eriksson P, Brattström D, Hesselius P, Larsson A, Bergström S, Ekman S, Goike H, Wagenius G, Brodin O, Bergqvist M. Eriksson P, et al. Among authors: ekman s. Neoplasma. 2006;53(4):285-90. Neoplasma. 2006. PMID: 16830054

3

Activation of growth factor receptors in esophageal cancer--implications for therapy.

Ekman S, Bergqvist M, Heldin CH, Lennartsson J. Ekman S, et al. Oncologist. 2007 Oct;12(10):1165-77. doi: 10.1634/theoncologist.12-10-1165. Oncologist. 2007. PMID: 17962610 Free article. Review.

4

The role of circulating angiogenic factors in patients operated on for localized malignant melanoma.

Bolander A, Wagenius G, Larsson A, Brattström D, Ullenhag G, Hesselius P, Ekman S, Bergqvist M. Bolander A, et al. Among authors: ekman s. Anticancer Res. 2007 Sep-Oct;27(5A):3211-7. Anticancer Res. 2007. PMID: 17970063 Free article.

5

Clinical value of using serological cytokeratins as therapeutic markers in thoracic malignancies.

Ekman S, Eriksson P, Bergström S, Johansson P, Goike H, Gullbo J, Henriksson R, Larsson A, Bergqvist M. Ekman S, et al. Anticancer Res. 2007 Sep-Oct;27(5B):3545-53. Anticancer Res. 2007. PMID: 17972516 Free article. Review.

6

Esophageal cancer: current and emerging therapy modalities.

Ekman S, Dreilich M, Lennartsson J, Wallner B, Brattström D, Sundbom M, Bergqvist M. Ekman S, et al. Expert Rev Anticancer Ther. 2008 Sep;8(9):1433-48. doi: 10.1586/14737140.8.9.1433. Expert Rev Anticancer Ther. 2008. PMID: 18759695 Review.

7

Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.

Bolander A, Agnarsdóttir M, Wagenius G, Strömberg S, Pontén F, Ekman S, Brattström D, Larsson A, Einarsson R, Ullenhag G, Hesselius P, Bergqvist M. Bolander A, et al. Among authors: ekman s. Melanoma Res. 2008 Dec;18(6):412-9. doi: 10.1097/CMR.0b013e328315c690. Melanoma Res. 2008. PMID: 19011512

8

Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin.

Wu X, Wanders A, Wardega P, Tinge B, Gedda L, Bergstrom S, Sooman L, Gullbo J, Bergqvist M, Hesselius P, Lennartsson J, Ekman S. Wu X, et al. Among authors: ekman s. Br J Cancer. 2009 Jan 27;100(2):334-43. doi: 10.1038/sj.bjc.6604855. Epub 2009 Jan 13. Br J Cancer. 2009. PMID: 19142186 Free PMC article.

9

Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data.

Göransson H, Edlund K, Rydåker M, Rasmussen M, Winquist J, Ekman S, Bergqvist M, Thomas A, Lambe M, Rosenquist R, Holmberg L, Micke P, Botling J, Isaksson A. Göransson H, et al. Among authors: ekman s. PLoS One. 2009 Jun 26;4(6):e6057. doi: 10.1371/journal.pone.0006057. PLoS One. 2009. PMID: 19557126 Free PMC article.

10

Impact of age at diagnosis on prognosis and treatment in laryngeal cancer.

Reizenstein JA, Bergström SN, Holmberg L, Linder A, Ekman S, Blomquist E, Lödén B, Holmqvist M, Hellström K, Nilsson CO, Brattström D, Bergqvist M. Reizenstein JA, et al. Among authors: ekman s. Head Neck. 2010 Aug;32(8):1062-8. doi: 10.1002/hed.21292. Head Neck. 2010. PMID: 19953624

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters